Plasma Archives - EMEA

This site provides INTERCEPT product information for International audiences .

Experiences of standardized volume, pathogen-reduced, pooled plasma for faster availability of components for transfusion

Experiences of standardized volume, pathogen-reduced, pooled plasma for faster availability of components for transfusion

by jaycornell | May 6, 2025

Ms. Marja-Kaisa Auvinen, MD, PhD Uppsala University Hospital Uppsala, Sweden

Overview of the variability in platelet production processes and applied safety measures

Overview of the variability in platelet production processes and applied safety measures

by jaycornell | May 6, 2025

Dr. Mohammad R. Abedi, MD, PhD Örebro University Hospital Stockholm, Sweden

Cryoprecipitate from pathogen reduced concurrent apheresis plasma

Cryoprecipitate from pathogen reduced concurrent apheresis plasma

by jaycornell | May 5, 2025

Dr. Konrad Rosskopf, MD Medical University Graz Graz, Austria

Production and in vitro quality of pooled whole blood derived PI plasma

Production and in vitro quality of pooled whole blood derived PI plasma

by jaycornell | May 5, 2025

Dr. sc. nat. David Goslings, MBA Blood Transfusion Service Zurich Zurich, Switzerland

Production and in vitro quality of pooled whole blood derived PI plasma

Production and in vitro quality of pooled whole blood derived PI plasma

by jaycornell | May 5, 2025

Dr. sc. nat. David Goslings, MBA Blood Transfusion Service Zurich Zurich, Switzerland

« Older Entries